Meta-analysis of randomized controlled trials of bosentan for treatment of pulmonary arterial hypertension

Efficacy and Safety of Monthly 150 mg Oral Ibandronate in Women with Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials

(2011) Young Ho Lee et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Meta-Analysis of Randomized Controlled Trials on Treatment of Pulmonary Arterial Hypertension

(2010) Bing He et al.   CIRCULATION JOURNAL

Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease

(2009) Giuseppe Valerio et al.   Therapeutic Advances in Respiratory Disease

A randomised, controlled trial of bosentan in severe COPD

(2008) D. Stolz et al.   EUROPEAN RESPIRATORY JOURNAL

Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension

(2008) Xavier Jaïs et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

(2008) N Galiè et al.   LANCET